{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:23:51Z","timestamp":1789161831761,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004291","name":"Saurashtra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pharma.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:23:02Z","timestamp":1728987782000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and in vitro-in vivo evaluation of ocular insert containing ketorolac tromethamine and moxifloxacin hydrochloride"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2849-9746","authenticated-orcid":false,"given":"Krishna","family":"Koradia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Dedakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3841-735X","authenticated-orcid":false,"given":"Hiral","family":"Koradia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.10.002_bib0205","doi-asserted-by":"crossref","first-page":"100045","DOI":"10.1016\/j.fhfh.2021.100045","article-title":"Fabrication of nanoemulsion-based in situ gel using moxifloxacin hydrochloride as model drug for the treatment of conjunctivitis","volume":"1","author":"Prajapati","year":"2021","journal-title":"Food Hydrocoll Health"},{"issue":"3","key":"10.1016\/j.pharma.2024.10.002_bib0210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","article-title":"Conjunctivitis: a systematic review","volume":"15","author":"Azari","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2018.06.059","article-title":"Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis","volume":"548","author":"Maulvi","year":"2018","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.pharma.2024.10.002_bib0220","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12325-011-0037-x","article-title":"Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis","volume":"28","author":"Tauber","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.pharma.2024.10.002_bib0225","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1016\/j.jscs.2014.04.004","article-title":"Application of experimental design and response surface technique for selecting the optimum RP-HPLC conditions for the determination of moxifloxacin HCl and ketorolac tromethamine in eye drops","volume":"21","author":"Kalariya","year":"2017","journal-title":"J Saudi Chem Soc"},{"key":"10.1016\/j.pharma.2024.10.002_bib0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-14-140","article-title":"Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review","volume":"14","author":"Al-Omari","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.pharma.2024.10.002_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rinphs.2015.06.001","article-title":"Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride","volume":"6","author":"Makwana","year":"2016","journal-title":"Results Pharma Sci"},{"issue":"2","key":"10.1016\/j.pharma.2024.10.002_bib0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02854842","article-title":"Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis","volume":"17","author":"Donshik","year":"2000","journal-title":"Adv Ther"},{"issue":"5\u20136","key":"10.1016\/j.pharma.2024.10.002_bib0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/02713680802023104","article-title":"Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert","volume":"33","author":"Mundada","year":"2008","journal-title":"Curr Eye Res"},{"issue":"11","key":"10.1016\/j.pharma.2024.10.002_bib0250","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.addr.2006.07.022","article-title":"Industrial perspective in ocular drug delivery","volume":"58","author":"Ali","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.pharma.2024.10.002_bib0255","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.82.10.1131","article-title":"Ocular contact time of a carbomer gel (GelTears) in humans","volume":"82","author":"Wilson","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00175-X","article-title":"Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies","volume":"83","author":"Wei","year":"2002","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2024.10.002_bib0270","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro\/in vivo evaluation","volume":"12","author":"Aburahma","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.pharma.2024.10.002_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","article-title":"Adverse effects of topical antiglaucoma drugs on the ocular surface","volume":"28","author":"Arici","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2024.10.002_bib0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","article-title":"Development of a poloxamer analogs\/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin","volume":"337","author":"Qi","year":"2007","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","article-title":"Ocular inserts for topical delivery","volume":"16","author":"Saettone","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03639049509048094","article-title":"Patent literature review of ophthalmic inserts","volume":"21","author":"Gurtler","year":"1995","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.pharma.2024.10.002_bib0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0110-5558.72419","article-title":"Ocular inserts\u00a0\u2013\u00a0advancement in therapy of eye diseases","volume":"1","author":"Kumari","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"issue":"7","key":"10.1016\/j.pharma.2024.10.002_bib0300","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s12272-013-0317-x","article-title":"Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia","volume":"37","author":"Shukr","year":"2014","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0305","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10717544.2010.509366","article-title":"Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E2-induced ocular inflammation","volume":"18","author":"Mathurm","year":"2011","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.pharma.2024.10.002_bib0310","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1872211311666170213105001","article-title":"Preparation and optimization of fast dissolving film of naratriptan hydrochloride","volume":"11","author":"Krishna","year":"2017","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.pharma.2024.10.002_bib0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jddst.2016.01.008","article-title":"Ocular inserts based on chitosan and brimonidine tartrate: development, characterization and biocompatibility","volume":"32","author":"De Souza","year":"2016","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10717544.2010.509366","article-title":"Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E2-induced ocular inflammation","volume":"18","author":"Mathurm","year":"2011","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharma.2024.10.002_bib0325","first-page":"139","article-title":"In vitro and in vivo evaluation of ocular inserts of ofloxacin","volume":"15","author":"Tanwar","year":"2007","journal-title":"Daru"},{"key":"10.1016\/j.pharma.2024.10.002_bib0330","first-page":"1","article-title":"In vitro and in vivo evaluation of timolol maleate ocular inserts using different polymers","volume":"3","author":"Attia","year":"2012","journal-title":"J Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.pharma.2024.10.002_bib0335","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/03639040500534101","article-title":"Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride","volume":"32","author":"Mundada","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/ph16010090","article-title":"Preparation and characterization of ion-sensitive brimonidine tartrate in situ gel for ocular delivery","volume":"16","author":"Xu","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.pharma.2024.10.002_bib0345","first-page":"309","article-title":"Development and evaluation of ocular films of cromolyn sodium","volume":"66","author":"Dandagi","year":"2004","journal-title":"Indian J Pharm Sci"},{"issue":"6","key":"10.1016\/j.pharma.2024.10.002_bib0350","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13346-021-01043-z","article-title":"In vitro dissolution testing models of ocular implants for posterior segment drug delivery","volume":"12","author":"Adrianto","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"10.1016\/j.pharma.2024.10.002_bib0355","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10837450.2020.1849283","article-title":"Mucoadhesive polymeric films comprising polyvinyl alcohol, polyvinylpyrrolidone, and poloxamer 407 for pharmaceutical applications.Pharm","volume":"26","author":"Vecchi","year":"2021","journal-title":"Dev Technol"},{"key":"10.1016\/j.pharma.2024.10.002_bib0360","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.matpr.2021.07.008","article-title":"Fabrication and characterization of new combination ocular insert for the combined delivery of tinidazole and levofloxacin","volume":"80","author":"Noori","year":"2023","journal-title":"Mater Today Proc"},{"issue":"3","key":"10.1016\/j.pharma.2024.10.002_bib0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/0973-8398.104836","article-title":"Design and evaluation of guar gum-based ofloxacin sustained release ocular insert","volume":"6","author":"Kumar","year":"2014","journal-title":"Asian J Pharm"},{"issue":"6","key":"10.1016\/j.pharma.2024.10.002_bib0370","first-page":"2312","volume":"118","author":"Pushp","year":"2021","journal-title":"Plasticized poly(vinylalcohol) and poly(vinylpyrrolidone) based patches with tunable mechanical properties for cardiac tissue engineering applications"},{"issue":"2","key":"10.1016\/j.pharma.2024.10.002_bib0375","first-page":"193","article-title":"Optimization of in vitro permeation pattern of ketorolac tromethamine transdermal patches","volume":"10","author":"Kumar De","year":"2011","journal-title":"Iran J Pharm Res"},{"issue":"3","key":"10.1016\/j.pharma.2024.10.002_bib0380","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/02726351.2017.1383330","article-title":"Preparation and characterization of ketorolac tromethamine-loaded ethyl cellulose micro-\/nanospheres using different techniques","volume":"37","author":"Wagh","year":"2019","journal-title":"Part Sci Technol"},{"key":"10.1016\/j.pharma.2024.10.002_bib0385","doi-asserted-by":"crossref","first-page":"128040","DOI":"10.1016\/j.molstruc.2020.128040","article-title":"Molecular structure, spectroscopic (FT-IR, FT-Raman, NMR, UV-VIS), chemical reactivity and biological examinations of ketorolac","volume":"1210","author":"Amul","year":"2020","journal-title":"J Mol Struct"},{"issue":"7","key":"10.1016\/j.pharma.2024.10.002_bib0390","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/gels8070418","article-title":"Formulation and evaluation of moxifloxacin loaded bilosomes in situ gel: optimization to antibacterial evaluation","volume":"8","author":"Zafar","year":"2022","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40543-018-0147-z","article-title":"Synthesis of moxifloxacin\u2013Au (III) and Ag (I) metal complexes and their biological activities","volume":"9","author":"Seku","year":"2018","journal-title":"J Anal Sci Technol"},{"issue":"1","key":"10.1016\/j.pharma.2024.10.002_bib0400","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jmrt.2018.04.023","article-title":"Characterization and some physical studies of PVA\/PVP filled with MWCNTs","volume":"8","author":"Zidan","year":"2019","journal-title":"J Mater Res Technol"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T09:06:32Z","timestamp":1738659992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0003450924001561"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.10.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and in vitro-in vivo evaluation of ocular insert containing ketorolac tromethamine and moxifloxacin hydrochloride","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}